Clearmind Medicine (FRA:CWY0) Scaled Net Operating Assets: -0.18 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CWY0 Clearmind Medicine Inc FRA:CWY0
22 GF Score
Price €22.56
! 1 Warning Sign
View Full Analysis

What is Clearmind Medicine Scaled Net Operating Assets?

Clearmind Medicine FRA:CWY0 22 Scaled Net Operating Assets is -0.18 as of Apr. 2026. GuruFocus rates FRA:CWY0 with a GF Score™ of 22/100. The stock has 1 warning sign investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Clearmind Medicine's operating assets for the quarter that ended in Apr. 2026 was €0.80 Mil. Clearmind Medicine's operating liabilities for the quarter that ended in Apr. 2026 was €2.52 Mil. Clearmind Medicine's Total Assets for the quarter that ended in Jan. 2026 was €9.48 Mil. Therefore, Clearmind Medicine's scaled net operating assets (SNOA) for the quarter that ended in Apr. 2026 was -0.18.


Clearmind Medicine Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Clearmind Medicine's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clearmind Medicine Scaled Net Operating Assets Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only 0.43 -0.39 -5.12 -0.60 -0.34

Clearmind Medicine Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.32 -0.45 -0.66 -0.34 -0.18

FRA:CWY0 vs ONCO, PPCB, REVB: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Clearmind Medicine's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearmind Medicine Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's Scaled Net Operating Assets falls into.


FRA:CWY0
22GF Score
Clearmind Medicine Inc FRA:CWY0
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clearmind Medicine Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Clearmind Medicine's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Oct. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Oct. 2025 )
=(Operating Assets (A: Oct. 2025 )-Operating Liabilities (A: Oct. 2025 ))/Total Assets (A: Oct. 2024 )
=(0.427-2.673)/6.66
=-0.34

where

Operating Assets(A: Oct. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=5.225 - 4.798
=0.427

Operating Liabilities(A: Oct. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=4.201 - 0 - 1.528
=2.673

Clearmind Medicine's Scaled Net Operating Assets (SNOA) for the quarter that ended in Apr. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Apr. 2026 )
=(Operating Assets (Q: Apr. 2026 )-Operating Liabilities (Q: Apr. 2026 ))/Total Assets (Q: Jan. 2026 )
=(0.796-2.52)/9.483
=-0.18

where

Operating Assets(Q: Apr. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=12.418 - 11.622
=0.796

Operating Liabilities(Q: Apr. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2.593 - 0.038 - 0.035
=2.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -0.18 mean?
Clearmind Medicine (FRA:CWY0) has a Scaled Net Operating Assets of -0.18 as of Apr. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Clearmind Medicine and its competitors.
Is Clearmind Medicine's Scaled Net Operating Assets too high?
Clearmind Medicine's current Scaled Net Operating Assets is -0.18. Overall, Clearmind Medicine has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Clearmind Medicine's Scaled Net Operating Assets compare to ONCO and PPCB?
Clearmind Medicine's Scaled Net Operating Assets of -0.18 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Clearmind Medicine and its competitors. Clearmind Medicine's current Scaled Net Operating Assets is -0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clearmind Medicine stock overvalued right now?
Clearmind Medicine (FRA:CWY0) has a current Scaled Net Operating Assets of -0.18. The current Scaled Net Operating Assets is -0.18. Clearmind Medicine's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Clearmind Medicine (FRA:CWY0), the current Scaled Net Operating Assets is -0.18 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clearmind Medicine Business Description

Other Exchanges CMND:USA
Address 101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H1A5
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
22GF Score

Get the complete analysis for FRA:CWY0

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.56
Price